NR4A1 and breast carcinoma: Patients after breast cancer treatment were divided into subgroups according to the following characteristics: the presence of lymphedema, limitation of movement in the shoulder joint, hormone receptor status of breast cancer, major pathological grades of breast cancer, operation type, and history of radiation therapy and chemotherapy.